MEF2C regulates cortical inhibitory and excitatory synapses and behaviors relevant to neurodevelopmental disorders

eLife

Volumn 5, Issue OCTOBER2016, 2016, Pages

  Harrington, Adam J ^a,b   Raissi, Aram ^b   Rajkovich, Kacey ^c   Berto, Stefano ^c   Kumar, Jaswinder ^b,d   Molinaro, Gemma ^c   Raduazzo, Jonathan ^b   Guo, Yuhong ^b   Loerwald, Kris ^c   Konopka, Genevieve ^c   Huber, Kimberly M ^c   Cowan, Christopher W ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2C; UNCLASSIFIED DRUG; MEF2C PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; BRAIN CELL; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; EXCITATORY SYNAPSE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INHIBITORY SYNAPSE; LUCIFERASE ASSAY; MENTAL DISEASE; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNAPSE; SYNAPTIC TRANSMISSION; WESTERN BLOTTING; ANIMAL; ANIMAL BEHAVIOR; BRAIN CORTEX; EMBRYOLOGY; GENE SILENCING; HIPPOCAMPUS; INTELLECTUAL IMPAIRMENT; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; AUTISTIC DISORDER; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; GENE KNOCKDOWN TECHNIQUES; HIPPOCAMPUS; INTELLECTUAL DISABILITY; MEF2 TRANSCRIPTION FACTORS; MICE; NEURODEVELOPMENTAL DISORDERS; SYNAPSES;

EID: 84994462724     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.20059     Document Type: Article

References (70)

1. Adachi M, Lin PY, Pranav H, Monteggia LM. 2016. Postnatal loss of Mef2c results in dissociation of effects on synapse number and learning and memory. Biological Psychiatry 80: 140-148. doi: 10.1016/j.biopsych.2015.09. 018, PMID: 26642739
2. American Psychiatric Association,. 2013. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed Washington, D.C: American Psychiatric Association. p947
3. Anders S, Huber W. 2010. Differential expression analysis for sequence count data. Genome Biology 11: R106. doi: 10.1186/gb-2010-11-10-r106, PMID: 20979621
4. Anders S, Pyl PT, Huber W. 2015. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 31: 166-169. doi: 10.1093/bioinformatics/btu638, PMID: 25260700
5. Arnold MA, Kim Y, Czubryt MP, Phan D, McAnally J, Qi X, Shelton JM, Richardson JA, Bassel-Duby R, Olson EN. 2007. MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Developmental Cell 12: 377-389. doi: 10.1016/j.devcel.2007.02.004, PMID: 17336904
6. Avale ME, Falzone TL, Gelman DM, Low MJ, Grandy DK, Rubinstein M. 2004. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. Molecular Psychiatry 9: 718-726. doi: 10.1038/sj.mp.4001474, PMID: 14699433
7. Barbosa AC, Kim M-S, Ertunc M, Adachi M, Nelson ED, McAnally J, Richardson JA, Kavalali ET, Monteggia LM, Bassel-Duby R, Olson EN. 2008. MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function. PNAS 105: 9391-9396. doi: 10.1073/pnas.0802679105
8. Basu SN, Kollu R, Banerjee-Basu S. 2009. AutDB: a gene reference resource for autism research. Nucleic Acids Research 37: D832-D836. doi: 10.1093/nar/gkn835, PMID: 19015121
9. Bateup HS, Johnson CA, Denefrio CL, Saulnier JL, Kornacker K, Sabatini BL. 2013. Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis. Neuron 78: 510-522. doi: 10.1016/j.neuron.2013.03.017, PMID: 23664616
10. Beaudoin GM, Lee SH, Singh D, Yuan Y, Ng YG, Reichardt LF, Arikkath J. 2012. Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex. Nature Protocols 7: 1741-1754. doi: 10.1038/nprot. 2012.099, PMID: 22936216
11. Ben-Ari Y, Gaiarsa JL, Tyzio R, Khazipov R. 2007. GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiological Reviews 87: 1215-1284. doi: 10.1152/physrev.00017.2006, PMID: 17928584
12. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, Thompson WJ, Barres BA. 2008. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. Journal of Neuroscience 28: 264-278. doi: 10.1523/JNEUROSCI.4178-07.2008, PMID: 18171944
13. Cardoso C, Boys A, Parrini E, Mignon-Ravix C, McMahon JM, Khantane S, Bertini E, Pallesi E, Missirian C, Zuffardi O, Novara F, Villard L, Giglio S, Chabrol B, Slater HR, Moncla A, Scheffer IE, Guerrini R. 2009. Periventricular heterotopia, mental retardation, and epilepsy associated with 5q14.3-q15 deletion. Neurology 72: 784-792. doi: 10.1212/01.wnl.0000336339.08878.2d, PMID: 19073947
14. Cellot G, Cherubini E. 2014. GABAergic signaling as therapeutic target for autism spectrum disorders. Frontiers in Pediatrics 2: 70. doi: 10.3389/fped.2014.00070, PMID: 25072038
15. Coyle JT, Balu DT, Puhl MD, Konopaske GT. 2016. History of the concept of disconnectivity in schizophrenia. Harvard Review of Psychiatry 24: 80-86. doi: 10.1097/HRP.0000000000000102, PMID: 26954593
16. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE, Stone EF, Chen C, Fak JJ, Chi SW, Licatalosi DD, Richter JD, Darnell RB. 2011. Fmrp stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146: 247-261. doi: 10.1016/j.cell.2011.06.013, PMID: 21784246
17. Deacon RM. 2006. Assessing nest building in mice. Nature Protocols 1: 1117-1119. doi: 10.1038/nprot.2006.170, PMID: 17406392
18. Deacon RM. 2006. Digging and marble burying in mice: simple methods for in vivo identification of biological impacts. Nature Protocols 1: 122-124. doi: 10.1038/nprot.2006.20, PMID: 17406223
19. Dichter GS, Richey JA, Rittenberg AM, Sabatino A, Bodfish JW. 2012. Reward circuitry function in autism during face anticipation and outcomes. Journal of Autism and Developmental Disorders 42: 147-160. doi: 10.1007/s10803-011-1221-1, PMID: 22187105
20. Engels H, Wohlleber E, Zink A, Hoyer J, Ludwig KU, Brockschmidt FF, Wieczorek D, Moog U, Hellmann-Mersch B, Weber RG, Willatt L, Kreiss-Nachtsheim M, Firth HV, Rauch A. 2009. A novel microdeletion syndrome involving 5q14.3-q15: clinical and molecular cytogenetic characterization of three patients. European Journal of Human Genetics 17: 1592-1599. doi: 10.1038/ejhg.2009.90, PMID: 19471318
21. Etherton MR, Blaiss CA, Powell CM, Sudhof TC. 2009. Mouse neurexin-1 deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. PNAS 106: 17998-18003. doi: 10.1073/pnas.0910297106
22. Ey E, Torquet N, Le Sourd AM, Leblond CS, Boeckers TM, Faure P, Bourgeron T. 2013. The Autism ProSAP1/ Shank2 mouse model displays quantitative and structural abnormalities in ultrasonic vocalisations. Behavioural Brain Research 256: 677-689. doi: 10.1016/j.bbr.2013.08.031, PMID: 23994547
23. Flavell SW, Cowan CW, Kim TK, Greer PL, Lin Y, Paradis S, Griffith EC, Hu LS, Chen C, Greenberg ME. 2006. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311: 1008-1012. doi: 10.1126/science.1122511, PMID: 16484497
24. Garber K. 2007. Neuroscience. Autism’s cause may reside in abnormalities at the synapse. Science 317: 190-191. doi: 10.1126/science.317.5835.190, PMID: 17626859
25. Gibson JR, Bartley AF, Hays SA, Huber KM. 2008. Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome. Journal of Neurophysiology 100: 2615-2626. doi: 10.1152/jn.90752.2008, PMID: 18784272
26. Hanson JL, Hurley LM. 2012. Female presence and estrous state influence mouse ultrasonic courtship vocalizations. PLoS ONE 7: e40782. doi: 10.1371/journal.pone.0040782, PMID: 22815817
27. Hays SA, Huber KM, Gibson JR. 2011. Altered neocortical rhythmic activity states in Fmr1 KO mice are due to enhanced mGluR5 signaling and involve changes in excitatory circuitry. Journal of Neuroscience 31: 14223-14234. doi: 10.1523/JNEUROSCI.3157-11.2011, PMID: 21976507
28. Huang da W, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 4: 44-57. doi: 10.1038/nprot.2008.211, PMID: 19131956
29. Inlow JK, Restifo LL. 2004. Molecular and comparative genetics of mental retardation. Genetics 166: 835-881. doi: 10.1534/genetics.166.2.835, PMID: 15020472
30. Insel TR. 2003. Is social attachment an addictive disorder? Physiology & Behavior 79: 351-357. doi: 10.1016/S0031-9384(03)00148-3, PMID: 12954430
31. Iwasato T, Inan M, Kanki H, Erzurumlu RS, Itohara S, Crair MC. 2008. Cortical adenylyl cyclase 1 is required for thalamocortical synapse maturation and aspects of layer IV barrel development. Journal of Neuroscience 28: 5931-5943. doi: 10.1523/JNEUROSCI.0815-08.2008, PMID: 18524897
32. Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W, Li Y, Baker SJ, Parada LF. 2006. Pten regulates neuronal arborization and social interaction in mice. Neuron 50: 377-388. doi: 10.1016/j.neuron.2006. 03.023, PMID: 16675393
33. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biology 10: R25. doi: 10.1186/gb-2009-10-3-r25, PMID: 19261174
34. Le Meur N, Holder-Espinasse M, Jaillard S, Goldenberg A, Joriot S, Amati-Bonneau P, Guichet A, Barth M, Charollais A, Journel H, Auvin S, Boucher C, Kerckaert JP, David V, Manouvrier-Hanu S, Saugier-Veber P, Frébourg T, Dubourg C, Andrieux J, Bonneau D. 2010. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations. Journal of Medical Genetics 47: 22-29. doi: 10.1136/jmg. 2009.069732, PMID: 19592390
35. Leifer D, Krainc D, Yu YT, McDermott J, Breitbart RE, Heng J, Neve RL, Kosofsky B, Nadal-Ginard B, Lipton SA. 1993. MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. PNAS 90: 1546-1550. doi: 10.1073/pnas.90.4.1546
36. Leifer D, Li YL, Wehr K. 1997. Myocyte-specific enhancer binding factor 2C expression in fetal mouse brain development. Journal of Molecular Neuroscience 8: 131-143. doi: 10.1007/BF02736778, PMID: 9188042
37. Li H, Radford JC, Ragusa MJ, Shea KL, McKercher SR, Zaremba JD, Soussou W, Nie Z, Kang Y-J, Nakanishi N, Okamoto S.-i., Roberts AJ, Schwarz JJ, Lipton SA. 2008. Transcription factor MEF2C influences neural stem/ progenitor cell differentiation and maturation in vivo. PNAS 105: 9397-9402. doi: 10.1073/pnas.0802876105
38. Lin Q, Schwarz J, Bucana C, Olson EN. 1997. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276: 1404-1407. doi: 10.1126/science.276.5317.1404, PMID: 9162005
39. Lubs HA, Stevenson RE, Schwartz CE. 2012. Fragile X and X-linked intellectual disability: four decades of discovery. The American Journal of Human Genetics 90: 579-590. doi: 10.1016/j.ajhg.2012.02.018, PMID: 224 82801
40. Lyons GE, Micales BK, Schwarz J, Martin JF, Olson EN. 1995. Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. Journal of Neuroscience 15: 5727-5738. PMID: 7643214
41. Lyons MR, Schwarz CM, West AE. 2012. Members of the myocyte enhancer factor 2 transcription factor family differentially regulate Bdnf transcription in response to neuronal depolarization. Journal of Neuroscience 32: 12780-12785. doi: 10.1523/JNEUROSCI.0534-12.2012, PMID: 22973001
42. McCarthy SE, Gillis J, Kramer M, Lihm J, Yoon S, Berstein Y, Mistry M, Pavlidis P, Solomon R, Ghiban E, Antoniou E, Kelleher E, O’Brien C, Donohoe G, Gill M, Morris DW, McCombie WR, Corvin A. 2014. De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Molecular Psychiatry 19: 652-658. doi: 10.1038/mp.2014.29, PMID: 24776741
43. McKinsey TA, Zhang CL, Olson EN. 2002. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends in Biochemical Sciences 27: 40-47. doi: 10.1016/S0968-0004(01)02031-X, PMID: 11796223
44. Mikhail FM, Lose EJ, Robin NH, Descartes MD, Rutledge KD, Rutledge SL, Korf BR, Carroll AJ. 2011. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders. American Journal of Medical Genetics Part A 155A: 2386-2396. doi: 10.1002/ajmg.a.34177, PMID: 22031302
45. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. 2008. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nature Methods 5: 621-628. doi: 10.1038/nmeth.1226, PMID: 18516045
46. Novara F, Beri S, Giorda R, Ortibus E, Nageshappa S, Darra F, Dalla Bernardina B, Zuffardi O, Van Esch H. 2010. Refining the phenotype associated with MEF2C haploinsufficiency. Clinical Genetics 78: 471-477. doi: 10.1111/j.1399-0004.2010.01413.x, PMID: 20412115
47. Paciorkowski AR, Traylor RN, Rosenfeld JA, Hoover JM, Harris CJ, Winter S, Lacassie Y, Bialer M, Lamb AN, Schultz RA, Berry-Kravis E, Porter BE, Falk M, Venkat A, Vanzo RJ, Cohen JS, Fatemi A, Dobyns WB, Shaffer LG, Ballif BC, et al. 2013. MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways. Neurogenetics 14: 99-111. doi: 10.1007/s10048-013-0356-y, PMID: 23389741
48. Petrini EM, Barberis A. 2014. Diffusion dynamics of synaptic molecules during inhibitory postsynaptic plasticity. Frontiers in Cellular Neuroscience 8: 300. doi: 10.3389/fncel.2014.00300, PMID: 25294987
49. Pfeiffer BE, Zang T, Wilkerson JR, Taniguchi M, Maksimova MA, Smith LN, Cowan CW, Huber KM. 2010. Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2. Neuron 66: 191-197. doi: 10.1016/j.neuron.2010.03.017, PMID: 20434996
50. Pirooznia M, Wang T, Avramopoulos D, Valle D, Thomas G, Huganir RL, Goes FS, Potash JB, Zandi PP. 2012. SynaptomeDB: an ontology-based knowledgebase for synaptic genes. Bioinformatics 28: 897-899. doi: 10. 1093/bioinformatics/bts040, PMID: 22285564
51. Pulipparacharuvil S, Renthal W, Hale CF, Taniguchi M, Xiao G, Kumar A, Russo SJ, Sikder D, Dewey CM, Davis MM, Greengard P, Nairn AC, Nestler EJ, Cowan CW. 2008. Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron 59: 621-633. doi: 10.1016/j.neuron.2008.06.020, PMID: 18760698
52. Renthal W, Maze I, Krishnan V, Covington HE, Xiao G, Kumar A, Russo SJ, Graham A, Tsankova N, Kippin TE, Kerstetter KA, Neve RL, Haggarty SJ, McKinsey TA, Bassel-Duby R, Olson EN, Nestler EJ. 2007. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 56: 517-529. doi: 10.1016/j.neuron.2007.09.032, PMID: 17988634
53. Ropers HH. 2008. Genetics of intellectual disability. Current Opinion in Genetics & Development 18: 241-250. doi: 10.1016/j.gde.2008.07.008
54. Rubenstein JL. 2010. Three hypotheses for developmental defects that may underlie some forms of autism spectrum disorder. Current Opinion in Neurology 23: 118-123. doi: 10.1097/WCO.0b013e328336eb13, PMID: 20087182
55. Scattoni ML, Gandhy SU, Ricceri L, Crawley JN. 2008. Unusual repertoire of vocalizations in the BTBR T+tf/J mouse model of autism. PLoS ONE 3: e3067. doi: 10.1371/journal.pone.0003067, PMID: 18728777
56. Schizophrenia Working Group of the Psychiatric Genomics Consortium. 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511: 421-427. doi: 10.1038/nature13595, PMID: 25056061
57. Shalizi A, Gaudillière B, Yuan Z, Stegmüller J, Shirogane T, Ge Q, Tan Y, Schulman B, Harper JW, Bonni A. 2006. A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science 311: 1012-1017. doi: 10.1126/science.1122513, PMID: 16484498
58. Shalizi AK, Bonni A. 2005. brawn for brains: the role of MEF2 proteins in the developing nervous system. Current Topics in Developmental Biology 69: 239-266. doi: 10.1016/S0070-2153(05)69009-6, PMID: 16243602
59. Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM, Südhof TC. 2007. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318: 71-76. doi: 10.1126/science.1146221, PMID: 17823315
60. Trapnell C, Pachter L, Salzberg SL. 2009. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111. doi: 10.1093/bioinformatics/btp120, PMID: 19289445
61. Tsai NP, Wilkerson JR, Guo W, Maksimova MA, DeMartino GN, Cowan CW, Huber KM. 2012. Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95. Cell 151: 1581-1594. doi: 10.1016/j.cell.2012.11.040, PMID: 23260144
62. van Bokhoven H. 2011. Genetic and epigenetic networks in intellectual disabilities. Annual Review of Genetics 45: 81-104. doi: 10.1146/annurev-genet-110410-132512, PMID: 21910631
63. Wang DD, Kriegstein AR. 2008. GABA regulates excitatory synapse formation in the neocortex via NMDA receptor activation. Journal of Neuroscience 28: 5547-5558. doi: 10.1523/JNEUROSCI.5599-07.2008, PMID: 1 8495889
64. Wehner JM, Radcliffe RA. 2004. Cued and contextual fear conditioning in mice. Current Protocols in Neuroscience Chapter 8. doi: 10.1002/0471142301.ns0805cs27, PMID: 18428608
65. Wilkerson JR, Tsai NP, Maksimova MA, Wu H, Cabalo NP, Loerwald KW, Dictenberg JB, Gibson JR, Huber KM. 2014. A role for dendritic mGluR5-mediated local translation of Arc/Arg3.1 in MEF2-dependent synapse elimination. Cell Reports 7: 1589-1600. doi: 10.1016/j.celrep.2014.04.035, PMID: 24857654
66. Williams MR, DeSpenza T, Li M, Gulledge AT, Luikart BW. 2015. Hyperactivity of newborn Pten knock-out neurons results from increased excitatory synaptic drive. Journal of Neuroscience 35: 943-959. doi: 10.1523/JNEUROSCI.3144-14.2015, PMID: 25609613
67. Zang T, Maksimova MA, Cowan CW, Bassel-Duby R, Olson EN, Huber KM. 2013. Postsynaptic FMRP bidirectionally regulates excitatory synapses as a function of developmental age and MEF2 activity. Molecular and Cellular Neuroscience 56: 39-49. doi: 10.1016/j.mcn.2013.03.002, PMID: 23511190
68. Zhang B, Kirov S, Snoddy J. 2005. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Research 33: W741-W748. doi: 10.1093/nar/gki475, PMID: 15980575
69. Zoghbi HY. 2003. Postnatal neurodevelopmental disorders: meeting at the synapse? Science 302: 826-830. doi: 10.1126/science.1089071, PMID: 14593168
70. Zweier M, Gregor A, Zweier C, Engels H, Sticht H, Wohlleber E, Bijlsma EK, Holder SE, Zenker M, Rossier E, Grasshoff U, Johnson DS, Robertson L, Firth HV, Ekici AB, Reis A, Rauch A., Cornelia Kraus. 2010. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression. Human Mutation 31: 722-733. doi: 10.1002/humu.21253, PMID: 20513142